Jamie Emerson v. HHS - Hepatitis B, uveitis and retinal migraines (2019)
Case summary [AI summaries can sometimes make mistakes]
Jamie Emerson filed a petition on January 15, 2015, seeking compensation under the National Vaccine Injury Compensation Program. She alleged that she suffered from uveitis and retinal migraines as a result of receiving the Hepatitis B vaccine on July 19, 2012, and that these conditions had residual effects for more than six months.
The respondent denied that the Hepatitis B vaccine caused Ms. Emerson's alleged injuries.
However, both parties agreed to settle the case through a stipulation filed on September 17, 2019. Special Master Brian H.
Corcoran reviewed the stipulation and found it to be reasonable, adopting it as the decision. The stipulation awarded Jamie Emerson a lump sum of $65,000.00, payable by check, as compensation for all damages.
The decision directed the clerk of the court to enter judgment accordingly. Ronald Craig Homer represented the petitioner, and Adriana Ruth Teitel represented the respondent.
The public decision does not describe the specific onset of symptoms, clinical details of the uveitis and retinal migraines, any diagnostic tests performed, or treatments received. It also does not name any medical experts or detail the specific mechanism by which the Hepatitis B vaccine allegedly caused the claimed conditions.
Theory of causation
Petitioner Jamie Emerson alleged that the Hepatitis B vaccine administered on July 19, 2012, caused her to suffer from uveitis and retinal migraines, with residual effects lasting more than six months. The respondent denied causation. The parties reached a settlement via stipulation, filed September 17, 2019, agreeing to an award of $65,000.00. Special Master Brian H. Corcoran adopted the stipulation as the decision. The public text does not specify the theory of causation, medical experts, or the mechanism of injury. The award was a lump sum of $65,000.00. Attorneys involved were Ronald Craig Homer for the petitioner and Adriana Ruth Teitel for the respondent. The decision date was November 18, 2019.
Source PDFs
USCOURTS-cofc-1_15-vv-00042